Acute Myeloid Leukemia in Remission Clinical Trials

38 clinical trials for Acute Myeloid Leukemia in Remission across international registries, including 7 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome — RECRUITING · PHASE1
• MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing — RECRUITING · NA
• Ziftomenib Maintenance Post Allo-HCT — RECRUITING · PHASE1
• Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT — RECRUITING · PHASE2
• Pilot Study of Reduced Venetoclax Exposure — RECRUITING · PHASE2
• Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) — RECRUITING · PHASE1
• Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning — RECRUITING · PHASE2
• Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• AZA + Venetoclax as Maintenance Therapy in Patients With AML in Remission — ACTIVE_NOT_RECRUITING · PHASE2
• Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome — SUSPENDED · PHASE1
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD — COMPLETED · PHASE2
• Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events — TERMINATED
• Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE1
• Ruxolitinib + Allogeneic Stem Cell Transplantation in AML — ACTIVE_NOT_RECRUITING · PHASE2
• CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant — ACTIVE_NOT_RECRUITING · PHASE1
• Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion — ACTIVE_NOT_RECRUITING · NA
• Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia — COMPLETED · PHASE1
• Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies — COMPLETED · PHASE2
• Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies — COMPLETED · PHASE1
• Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat — COMPLETED · PHASE2
• Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies — TERMINATED · PHASE1
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant — COMPLETED · PHASE2
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies — TERMINATED · PHASE2
• Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia — OTHER · PHASE2
• Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML — OTHER · PHASE3
• Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant — COMPLETED · PHASE1
• Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft — OTHER · PHASE2
• Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes — COMPLETED · PHASE2
• Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia — OTHER · PHASE2
• Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients. — OTHER · PHASE2
• Aerobic Versus Resistive Training on Functional Capacity in Acute Myeloid Leukemia — COMPLETED · NA
• NK Cells in Cord Blood Transplantation — OTHER · PHASE1
• Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia — COMPLETED · PHASE2
• Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant — WITHDRAWN · PHASE2
• Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer — COMPLETED · PHASE3
• Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis — WITHDRAWN · PHASE1
• Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies — COMPLETED · PHASE1

Refine this search